TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE CANNABIS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 TECHNOLOGY LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 MARKET APPLICATION COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 VENDOR SHARE ANALYSIS
2.13 IMPORT-EXPORT DATA
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 LEGALIZATION OF MEDICAL AND RECREATIONAL USE OF CANNABIS
3.1.2 MEDICAL ADVANTAGES OF CANNABIS
3.1.3 HIGH ADAPTATION OF CANNABIS FOR RECREATIONAL PURPOSES
3.1.4 INCREASED APPLICATIONS OF CANNABIS IN SECTORS OTHER THAN MEDICAL
3.2 RESTRAINTS
3.2.1 UNCLEAR REGULATORY ENVIRONMENT
3.2.2 SCARCITY OF WATER AND SUSTAINABLE AGRICULTURE
3.2.3 LACK OF AWARENESS RELATED TO BENEFITS OF CANNABIS
3.2.4 MARKETING AND ADVERTISEMENT RESTRICTIONS
3.3 OPPORTUNITIES
3.3.1 STANDARDIZATION IN CULTIVATION PRACTICES
3.3.2 INNOVATION IN VAREITY OF SATIVA PRODUCTS
3.3.3 LAUNCHING OF FROZEN CANNABIS BUDS
3.4 CHALLENGES
3.4.1 MEETING THE PREDICTIVE DEMAND POST-LEGALIZATION
3.4.2 HIGH TAXES IMPOSED ON CANNABIS
3.4.3 STRINGENT TRANSPORTATION AND STORAGE NORMS INCREASES WAREHOUSING COST
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE CANNABIS MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 BUDS
6.3 TINCTURES
6.4 OIL
6.5 OTHERS
7 EUROPE CANNABIS MARKET, BY USAGE
7.1 OVERVIEW
7.2 MEDICAL
7.2.1 CHRONIC PAIN
7.2.2 CANCER
7.2.3 MENTAL DISORDERS
7.2.4 OTHERS
7.3 RECREATIONAL
8 EUROPE CANNABIS MARKET, BY CROP VAREITY
8.1 OVERVIEW
8.2 CANNABIS INDICA
8.3 CANNABIS SATIVA
8.4 OTHERS
9 EUROPE CANNABIS MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 PHYSICAL
9.2.1 LICENSED PRIVATE RETAIL STORE
9.2.2 MANUFACTURER RETAIL STORE
9.2.3 GOVERNMENT RETAIL STORE
9.3 DIGITAL
9.3.1 MANUFACTURER WEBSITE
9.3.2 PRIVATE RETAIL WEBSITE
9.3.3 GOVERNMENT OPERATED WEBSITE
9.3.4 MANUFACTURER MOBILE APP
9.3.5 LICENSED PRIVATE RETAIL MOBILE APP
9.4 OTHERS
10 EUROPE CANNABIS MARKET, BY GEOGRAPHY
10.1 EUROPE
10.1.1 GERMANY
10.1.2 NETHERLANDS
10.1.3 SWITZERLAND
10.1.4 REST OF EUROPE
11 EUROPE CANNABIS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 SWOT ANALYSIS
12.1 DATA BRIDGE MARKET RESEARCH ANALYSIS
13 COMPANY PROFILES
13.1 AURORA CANNABIS
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 PRODUCT PORTFOLIO OF CANNIMED LTD. (A SUBSIDIARY OF AURORA CANNABIS)
13.1.6 PRODUCT PORTFOLIO OF MEDRELEAF CORP. (A SUBSIDIARY OF AURORA CANNABIS)
13.1.7 RECENT DEVELOPMENTS
13.2 CANOPY GROWTH CORPORATION
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 THE SCOTTS COMPANY LLC
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENT
?
13.4 TILRAY
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 THE CRONOS GROUP
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 O.PENVAPE
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 MARLEY NATURAL
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 CARA THERAPEUTICS
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 ARUMA LABS HOLDINGS PTY LIMITED
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.10 MEDCAN AUSTRALIA
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
13.11 SUNDIAL GROWERS INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
?
13.12 GW PHARMACEUTICALS PLC
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 INSYS THERAPEUTICS, INC.
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENTS
13.14 APHRIA INC.
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 VIVO CANNABIS
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 CANNATREK
13.16.1 COMPANY SNAPSHOT
13.16.2 PRODUCT PORTFOLIO
13.16.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 CONCLUSION
16 REFERENCES
17 RELATED REPORTS